"Drug addiction and opioid abuse are ravaging America.

New Post Public Reply Private Reply Replies (0) Message Board
PENNIEStoSTACKS
268
"Drug addiction and opioid abuse are ravaging America. Hundreds of thousands of Americans have lost their lives to drug abuse."

Quote:
The Opioid Crisis
More than 300,000 Americans have died from overdoses involving opioids since 2000. President Donald J. Trump has mobilized his entire Administration to address opioid abuse by directing the declaration of a nationwide Public Health Emergency.

https://www.whitehouse.gov/opioids

A system I helped to build.
https://investorshub.advfn.com/boards/read_ms...=146527442

Quote:
Dr. Dalton has
served as a Board member on such organizations as Blue Shield of
Pennsylvania, United Way, National Health Association, National
Association of Chain Drug Stores, and is one of the original
members and Directors of the National Council of Prescription
Drug Programs
which is the organization responsible for every
prescription transaction technology platform in the United
States.
https://www.twst.com/bio/david-l-dalton/


Look for DAVID DALTON
http://www.ncpdp.org/NCPDP/media/pdf/WP/NCPDP...f?ext=.pdf

Quote:
Health IT Now and the National Council for Prescription Drug Programs (NCPDP) — have embraced a nationwide, interoperable, and real-time drug monitoring program to stop fraudulent prescriptions before they reach the patient’s hands.

We’ve called it the Prescription Safety Alert System, based off the NCPDP Standards -based Model for PDMP: An Interoperable Framework for Patient Safety, but the name is much less important to us than the policy.

First envisioned in a 2016 NCPDP white paper, our solution would function as a facilitator that is run by the private sector under a contract with the federal government.

Importantly, the technology to do this is already exists. More than 20 years ago, NCPDP first developed its SCRIPT standard that paved the way for doctors to electronically send prescriptions to your pharmacy in real-time. More recently, its telecommunication standard wrote the rules of the road for how pharmacies communicate with patients’ insurance to instantly adjudicate claims.

Now we need to employ these tools to stem the tide of abuse by allowing clinicians to identify at-risk patients while ensuring access for those with a valid medical need, and we know it’s possible. Medicare Part D is using a similar system today, known as the “TrOOP” facilitator, to track out-of-pocket costs, making this a time-tested concept.

Under our plan, an alert system would instantly capture data each time a physician sends an electronic prescription for a controlled substance and each time a pharmacist seeks to fill an opioid prescription.

The private sector facilitator would use this information in conjunction with an algorithm to alert the prescriber or dispenser if a patient presents a risk — anything from a possible drug interaction to an individual who may have already filled a prescription moments ago at another pharmacy across the street.

The result? Clinicians have real-time information before prescribing a controlled substance. Moreover, the solution reduces the time clinicians spend trying to track down data and allows them to focus more time on patient care.

What’s more, with a recent study pegging the true economic cost of the opioid crisis at $500 billion a year, this solution can actually save taxpayer dollars, as physicians and pharmacists are empowered to catch problems before they become costly tragedies.

We have been hard at work championing this blueprint, and Washington is taking notice . Included in the White House’s new opioid plan released last week is a call for states to “transition to a nationally interoperable prescription drug monitoring program network” — a network like the Prescription Safety Alert System.
https://thehill.com/opinion/healthcare/380592...oid-crisis

Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 206

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 201

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 110

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading

Top 5 Most Recently Viewed Articles

Massive Trading Activity Spotted in Tempus AI (TEM) Options

Updated Category News Views 292

Unprecedented Trading Interest in Tempus AI Options Investors with significant capital are showing a strong bullish outlook on Tempus AI (TEM). This surge in trading activity is something every retail trader should pay attention to. Identifying Smart Money Moves Today, we observed notable trends in the options market for Tempus AI, highlighting the actions of big-money...

Continue Reading
Endeavour Mining Sees Significant Stake Notification from BlackRock

Updated Category News Views 143

Endeavour Mining and Major Shareholding Update Endeavour Mining plc is making headlines with its latest update regarding shareholders. Recently, the company received a notable notification from BlackRock, Inc., one of the world’s leading investment management firms. This announcement highlights BlackRock's interests in Endeavour Mining, showcasing the ongoing...

Continue Reading
Adverity Unveils Innovative Data Quality Suite for Clients

Updated Category News Views 188

Adverity launched its Data Quality Suite a while back, promising to revolutionize how businesses tackle data management. But let’s dig deeper—what’s the real deal here? Data Quality: A Marketing Essential or Just Noise? In this digital mess we call life, clean data isn’t just a luxury; it’s an absolute necessity. Back then, marketing and analytics teams faced a...

Continue Reading
Strengthening Medical Connections Between U.S. and Jordan

Updated Category News Views 225

Strengthening Medical Collaborations Dr. Maen Hussein, a talented medical oncologist and hematologist, recently held an important meeting with King Abdullah II of Jordan. This gathering aimed to enhance the collaboration between medical professionals in both the United States and Jordan, showcasing the commitment to elevate healthcare standards through shared knowledge...

Continue Reading
Alphabet's Stock Outlook Amid DOJ Challenges: Key Insights

Updated Category News Views 101

Alphabet's Price Target Change: Implications Recently, Evercore ISI adjusted its price target for Alphabet Inc. (NASDAQ: GOOGL), reducing it from $225 to $200. Even with this decrease, Evercore retains an Outperform rating for the stock. This change signals growing concerns over the ongoing antitrust trials led by the Department of Justice (DOJ), which could heavily...

Continue Reading